COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03849404
Recruitment Status : Active, not recruiting
First Posted : February 21, 2019
Last Update Posted : June 29, 2020
Information provided by (Responsible Party):
Alvotech Swiss AG

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 23, 2019
Estimated Study Completion Date : July 17, 2020